Skip to main content

Table 1 Baseline characteristics of the patients with type 1 diabetes

From: Progression to microalbuminuria in patients with type 1 diabetes: a seven-year prospective study

 

Total

Microalbuminuric group

Normoalbuminuric group

N

122

50

72

Gender (Male)

59(48.4)

21 (42.0)

38 (52,8)

Age (years)

17 (12.0-25.2)

20 (14-26)

14 (9-21)

Age at diagnosis (years)

12 (7.0-9.0)

14 (9-23)

11 (6-18)

Duration of diabetes (years)

3 (1.0-5.6)

4.0 (2.0-8.3)

2.0 (1.0-4.5)

Insulin dose (IU/Kg/day)

0.7 (0.46-0.99)

0.73 (0.59-1.12)

0.63 (0.44-0.98)

Systolic blood pressure (mmHg)

103 (97-110)

103 (100-110)

104 (97-110)

Diastolic blood pressure (mmHg)

68 (60-73)

69 (61-73)

68 (60-73)

Fasting plasma glycemia (mg/dl)

150 (110-233)

163 (123-253)

147 (108-224)

Two-hour post-prandial glycemia (mg/dl)

221 (148-312)

229 (148-345)

214 (149-306)

A1c (%)

7.2 (6.5-8.11)

7.0 (6.5-7.9)

7.3 (6.6-8.5)

Total cholesterol level (mg/dl)

158 (140-191)

164 (143-197)

157 (138-183)

Trygliceride level (mg/dl)

60 (46-81)

68 (50-97)

55 (44-73)

HDL cholesterol level (mg/dl)

49 (41-57)

49 (42-56)

48 (39-63)

LDL cholesterol level (mg/dl)

105 (86-137)

113 (92-14)

101 (83-121)

Cholesterol/HDL ratio

3.3 (2.7-4.1)

3.4 (2.8-4.2)

3.2 (2.6-4.0)

LDL/HDL ratio

2.3 (1.6-3.1)

2.5 (1.8-3.4)

2.0 (1.5-2.9)

Plasma creatinine level (mg/dl)

0.65(0.6-0.8)

0.7 (0.6-0.9)

0.6 (0.6-0.8)

Albumin excretion rate (μg/min)

7.0 (4.3-10.2)

7.4 (5.1-11.5)

6.8 (4.1-10.0)

BMI (kg/m 2 )

20 (18-22)

20.7 (18.9 22.7)

19.2 (17.1-21)

Overweight or obese

22 (18)

8 (16.0)

14 (19.4)

Presence of retinopathy *

6(5)

2 (4.1)

4 (5.6)

Family history of type 2 diabetes**

24(22)

13 (28,3)

11 (16,4)

  1. Continuous variables are presented as median (interquartile range), and categorical variables are presented as n (%).A1c, glycated hemoglobin; BMI, body mass index; HDL, high density lipoprotein; LDL, low density lipoprotein * 2 evaluations are missing ** Data from 8 subjects are missing